Mercer Global Advisors
BNTC icon

Mercer Global Advisors’s Benitec Biopharma BNTC Stock Holding History

Mercer Global Advisors’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.54K Buy
+713
New +$8.46K ﹤0.01% 5150

Other funds holding BNTC

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's BNTC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 713 shares worth $9.54K. The stake represents ﹤0.01% of the portfolio and ranks #5150 among its holdings.

53 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Mercer Global Advisors held 713 shares of Benitec Biopharma worth $9.54K as of Q2 2026.
  • Benitec Biopharma was a new Mercer Global Advisors position in Q2 2026.
  • Benitec Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5150 holding.
  • 53 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.